Enovis launches Spinamic scoliosis brace
Analysis based on 6 articles · First reported Jun 08, 2026 · Last updated Jun 08, 2026
The launch of the DonJoy Spinamic Hybrid Scoliosis Brace by Enovis is likely to have a positive impact on Enovis' stock price due to the introduction of an innovative medical device. This product could increase Enovis' market share in the medical technology industry, particularly in the scoliosis treatment segment.
Enovis Corporation, through its subsidiary DJO, LLC, has launched the DonJoy Spinamic Hybrid Scoliosis Brace in the United States. This new medical device combines rigid corrective elements with a breathable, adjustable design to improve clinical outcomes and patient compliance for adolescent idiopathic scoliosis. The brace is designed for effectiveness, comfort, and streamlined patient visits, allowing for fitting, imaging, and adjustments in a single visit. Enovis is also pursuing regulatory clearance for the Spinamic brace in additional markets worldwide. This launch reflects Enovis' commitment to delivering innovative solutions in medical technology.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard